Arizona Patent of the Month – January 2024
Vomaris Innovations, Inc. is directing their bioelectric technological expertise towards the control or infection. This is particularly important as we have experienced on a global level, how quickly infection and viruses can spread. Within this bid, the company has been granted a patent for their approach to preventing viral transmission.
This invention, focusing on viral transmission prevention, introduces a method that involves applying a low-level micro-current (LLEC) ranging from 1 to 200 micro-amperes to the mouth and nose, thereby reducing the infectivity of the coronavirus.
The core of this approach lies in the application of this LLEC system, featuring a pliable substrate adorned with a multi-array matrix of biocompatible microcells. This matrix comprises two arrays—one patterned with microcells made of a conductive material and another mirroring the pattern with a different conductive material. Together, these arrays can define at least one voltaic cell, spontaneously generating electrical current when introduced to an electrolytic solution.
To implement this method, the pliable substrate is affixed to the mouth and nose, offering a unique and effective means of viral transmission prevention. The invention not only addresses viral propagation but also viral acquisition, presenting a comprehensive approach to managing the spread of infections.
Noteworthy is the versatility of the invention, with the pliable substrate accommodating adhesive on opposite ends or around the perimeter. The microcells on the substrate can spontaneously generate a Low-Level Electric Field (LLEF) or LLEC, showcasing the adaptability of the invention.
What sets this innovation apart is its potential to be incorporated into various forms, including masks, respirators, or inserts, offering antiviral properties. This aligns with the present challenges in preventing viral transmission effectively, especially given the limitations of current filtration capabilities in commonplace protective gear like masks.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
